A HR20031 FE Study on Healthy Subjects

NCT05692934 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: HR20031 FDC
DRUG: HR20031 FDC
DRUG: HR20031 FDC
DRUG: HR20031 FDC

Sponsor

Shandong Suncadia Medicine Co., Ltd.